Literature DB >> 33360031

Biological correlates of early life stressful events in major depressive disorder.

Rosana Carvalho Silva1, Elisabetta Maffioletti2, Massimo Gennarelli3, Bernhard T Baune4, Alessandra Minelli5.   

Abstract

Major depressive disorder (MDD) is the most common psychiatric disorder and responds for important psychosocial consequences. Stressful life events, especially early life stress (ELS), contribute to an increased probability to develop MDD, leading in particular to severe and chronic manifestation and unfavorable treatment outcome. The association between ELS and MDD seems to have biological bases, consisting in dysregulations occurring at different levels. The aim of this narrative review is to propose an overview of the literature ranging from genetic, epigenetic, expression and protein to neuroimaging correlates underlying this relationship. A search on Pubmed of studies assessing biological correlates of ELS in MDD development, focusing on human studies conducted in both peripheral and brain tissues, was performed. Evidence indicated that the hypothalamic-pituitary-adrenal (HPA) axis and the serotonergic, dopaminergic, neurotrophin and oxytocin systems might play a role in the mediation between ELS and MDD. The most consistent results were found for genetic and epigenetic studies and indicated a joint involvement of the systems mentioned. Expression studies are less numerous and point to an involvement of stress-related systems. Concerning protein studies, the main mediators are markers related to the inflammatory and immune systems. Neuroimaging studies aiming at evaluating brain alterations connecting ELS and MDD in relation to biomarkers indicated the hippocampus, the amygdala and the frontal cortex as important anatomical mediators. These findings can build the bases for future research and clinical interventions; indeed, the clarification of biological mechanisms mediating the relationship between ELS and MDD can lead to new and individualized preventive and therapeutic possibilities.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomarkers; Childhood maltreatment; Early life stress; Epigenetics; Gene expression; Major depressive disorder (MDD)

Mesh:

Substances:

Year:  2020        PMID: 33360031     DOI: 10.1016/j.psyneuen.2020.105103

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  9 in total

1.  Approach-avoidance tendencies in depression and childhood trauma: No effect of noradrenergic stimulation.

Authors:  Christian Eric Deuter; Janna Smit; Michael Kaczmarczyk; Katja Wingenfeld; Christian Otte; Linn Kristina Kuehl
Journal:  Compr Psychoneuroendocrinol       Date:  2021-08-01

Review 2.  The oxytocin system and early-life experience-dependent plastic changes.

Authors:  Tatsushi Onaka; Yuki Takayanagi
Journal:  J Neuroendocrinol       Date:  2021-10-29       Impact factor: 3.870

3.  Yohimbine-Induced Reactivity of Heart Rate Variability in Unmedicated Depressed Patients With and Without Adverse Childhood Experience.

Authors:  Christian Eric Deuter; Christian Otte; Katja Wingenfeld; Linn Kristina Kuehl
Journal:  Front Psychiatry       Date:  2021-12-16       Impact factor: 4.157

4.  Intrinsic brain abnormalities in female major depressive disorder patients with childhood trauma: A resting-state functional magnetic resonance imaging study.

Authors:  Juran Chen; Qianyi Luo; Yuhong Li; Zhiyao Wu; Xinyi Lin; Jiazheng Yao; Huiwen Yu; Huiqin Nie; Yingying Du; Hongjun Peng; Huawang Wu
Journal:  Front Neurosci       Date:  2022-08-09       Impact factor: 5.152

Review 5.  Rodent models of early adversity: Impacts on developing social behavior circuitry and clinical implications.

Authors:  Katherine Packard; Maya Opendak
Journal:  Front Behav Neurosci       Date:  2022-08-04       Impact factor: 3.617

Review 6.  Using animal models for the studies of schizophrenia and depression: The value of translational models for treatment and prevention.

Authors:  Daniela L Uliana; Xiyu Zhu; Felipe V Gomes; Anthony A Grace
Journal:  Front Behav Neurosci       Date:  2022-08-24       Impact factor: 3.617

7.  Circulating microRNA associated with future relapse status in major depressive disorder.

Authors:  Qingqin S Li; David Galbraith; Randall L Morrison; Madhukar H Trivedi; Wayne C Drevets
Journal:  Front Psychiatry       Date:  2022-08-17       Impact factor: 5.435

Review 8.  Glucocorticoid Signaling and Epigenetic Alterations in Stress-Related Disorders.

Authors:  Niki Mourtzi; Amalia Sertedaki; Evangelia Charmandari
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

Review 9.  Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders.

Authors:  Shalini Dogra; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2021-06-25       Impact factor: 5.273

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.